German HTA of PET and CT for head/neck cancers "inconclusive"
This article was originally published in Clinica
A study conducted by German health technology assessment (HTA) agency IQWiG into the impact of using positron emission tomography (PET), alone or in combination with computed tomography (CT), in patients with head and neck tumours has proved inconclusive.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.